Development of extended-voyaging anti-oxidant Linked Amphiphilic Polymeric Nanomicelles for Anti-Tuberculosis Drug Delivery
Introduction
Tuberculosis (TB), which is caused by Mycobacterium tuberculosis and mainly affects the lungs, is one of the world’s most lethal communicable diseases (Amarnath Praphakar et al., 2016, Hasegawa et al., 2007, Choonara et al., 2011). Several antitubercular agents are used to control TB. Among these, the first line antitubercular agent, rifampicin (RF), which inhibits DNA-dependent RNA polymerase, is the most commonly used agent. In addition, trans-cinnamic acid derivatives have a wide range of therapeutic uses, including antitumor (Mishra et al., 2013), antioxidant (Sawant et al., 2014), and antibacterial activity (Torchilin et al., 2003). Cinnamic acid derivatives are also valid leads for use in the design and synthesis of M. tuberculosis inhibitors. They have good minimal inhibitory concentration (MIC) values and are extremely effective against M. tuberculosis (Park et al., 2001). Ferulic acid (4-hydroxy-3-methoxy cinnamic acid) is a cinnamic acid derivative which shows good antioxidant activity due to the presence of phenolic nucleus and extended conjugation (Graf, 1992). There are several effective drug regimens for TB; however, the disease still represents a major public health challenge primarily owing to the ease of transmission and the development of drug resistance (Ishida et al., 2001, Yang et al., 2009, Hu et al., 2008, Hu et al., 2012). Furthermore, the oral intake of RF results unwanted side effects such as hepatotoxicity, and the efficiency of anti-TB drugs can be hindered by poor solubility, drug permeability, and biodegradation (Liu et al., 2016, Hirota et al., 2010).
Amphiphilic polymeric micelles form the basis of novel nano-drug delivery systems and have been exploited for the oral delivery of poorly water-soluble drugs (Luo et al., 2016). Because of their amphiphilic nature, they self-assemble into nanoscale spherical structures with a hydrophobic inner core and a hydrophilic outer core in aqueous media (Koup et al., 1986). The hydrophobic inner core can incorporate a large amount of hydrophobic drugs, while the hydrophilic outer core can stabilize the micelles by reducing their interaction with serum proteins and tissues. They offer a simple approach for clinical treatment with reduced side effects, selective targeting, prolonged circulation time, and improved bioavailability and solubility of hydrophobic drugs (Zheng et al., 2016, Murugaraj Jeyaraj et al., 2016). Some drug moieties can be attached to the hydrophilic outer core of polymeric micelles, thereby enhancing therapeutic activity at the target site (Chen et al., 2003). To date, a number of surface modified polymeric micelles have been described, including those modified with antibodies (Chiu et al., 2010, Yang et al., 2011), transferrin (Adeleke et al., 2016, Dufes et al., 2004), and peptides (Aziz et al., 2006).
Chitosan shows good biocompatibility, biodegradability, mucoadhesivity, and non-cellular uptake, thereby making it an excellent backbone for drug delivery devices (Bezerra et al., 2006, Chung and Shin, 2007). In addition, chitosan itself possesses antibacterial activity (Naz et al., 2006). Despite these favorable characteristics, unmodified chitosan is a poor candidate for clinical use due to its pH-dependent solubility (Rajan and Raj, 2013). Therefore, chemical modification of chitosan (with either hydrophobic or hydrophilic moieties) is often used in order to overcome these drawbacks (Lepeltier et al., 2015, Yoder et al., 2004, Goyal et al., 2015, Kaur et al., 2016, Gelperina et al., 2005, Azarmi et al., 2008).
In the present work, we designed an amphiphilic polymer based on chitosan-grafted polycaprolactone for the dual delivery of FA and RF. First, chitosan was modified with caprolactone via microwave-assisted ring opening polymerization, and ferulic acid was conjugated via its carboxylate group onto an amino group of the chitosan backbone. Then, RF was encapsulated into the hydrophobic inner core of self-assembled CS-g-PCL/FA micelles. The physicochemical characteristics of CS-g-PCL/FA such as drug loading efficiency, swelling, critical micelle concentration (CMC), particle size, zeta potential, biodegradation, and in vitro drug release performance were studied. Characterization of antimicrobial activity, cytotoxicity and cellular uptake was performed. To investigate cytotoxicity, and cellular uptake, A549 cells was chosen as model cell line due to the presence of lysozyme to demonstrate the drug delivery.
Section snippets
Materials
Chitosan (CS), ferulic acid (FA), 1-ethyl-3-(3-dimethyl-aminopropyl) carbodiimide (EDC) and N-hydroxysuccinimide (NHS) were purchased from Himedia laboratories Pvt Ltd, India. Methanesulfonic acid, ε-caprolactone (CL), potassium dihydrogen phosphate, and sodium hydroxide were from Sigma Aldrich, India. RF was purchased from Alfa Aeser Chemicals. All other reagents and solvents were of analytical grade and used without purification.
Microwave-assisted ring-opening copolymerization of ε-caprolactone onto chitosan (CS-g-PCL)
The microwave-assisted graft copolymerization was carried out in
Synthesis of CS-g-PCL/FA nanomicelles
CS-g-PCL/FA was synthesized using a two-step procedure. In the first step, the graft copolymer (CS-g-PCL) was synthesized via a protection method in order to maintain free primary amino groups in the chitosan backbone. The graft polymerization of ε-CL with CS was carried out in the presence of MeSO3H, which acted as a protecting agent and the organic solvent. The route of CS-g-PCL copolymer synthesis is presented in Fig. 1. The protection renders CS soluble in MeSO3H, which facilitated the
Conclusion
Reduce the adverse effect of free radicals reaction, we are fabricated antioxidant (ferulic acid) conjugated a stable antitubercular amphiphilic polymeric micelle composed by chitosan and ε-caprolactone. FTIR and XRD studies revealed that clinically used drugs were compatible with these micelles. The high encapsulation efficiency conferred by the mixed micellar system provides a high solubilization potential for hydrophobic drugs. This composite system showed much higher loading capacities for
Conflicts of interest
The authors declare no competing financial interest.
Acknowledgements
M. Rajan is grateful to the DST-SERB, Government of India, for financial support under the scheme of “EMEQ” (F.No.- SB/EMEQ-241-2014) and University Grants Commission UGC-MRP scheme (Ref: No.F.43-187/2014 (SR)), New Delhi. The authors would like to extend their sincere appreciation to the Deanship of Scientific Research at King Saud University for its funding of this research through the Research Group project No RG 1435-057. M. Rajan thanks the DST-FIST program for the purchase of an FTIR,
References (50)
- et al.
Targeted delivery of rifampicin to tuberculosis-infected macrophages: design, in-vitro, and in-vivo performance of rifampicin-loaded poly(ester amide)s nanocarriers
Int. J. Pharm.
(2016) - et al.
Targeted delivery of nanoparticles for the treatment of lung diseases
Adv. Drug Deliv. Rev.
(2008) - et al.
Epidemiology of antituberculosis drug resistance (the global project of antituberculosis drug resistance surveillance): an updated analysis
Lancet
(2006) - et al.
A convenient way to synthesize comb-shaped chitosan-graft-poly (N-isopropylacrylamide) copolymer
Carbohydr. Polym.
(2013) - et al.
Cellular uptake and intracellular trafficking of nanoparticles made of hydrophobically modified chitosan
J. Control. Release
(2010) - et al.
Toxicological effects of inorganic nanoparticles on human lung cancer A549 cells
J. Inorg. Biochem.
(2009) - et al.
Polymeric emulsion and crosslink-mediated synthesis of super-stable nanoparticles as sustained-release anti-tuberculosis drug carriers
Colloids Surf. B: Biol.
(2011) - et al.
Characterization of antioxidant alkaloids and phenolic acids from anthocyanin-pigmented rice (Oryza sativa cv. Heugjinjubyeo)
Food Chem.
(2007) - et al.
Preparation of polysaccharide derivates chitosan-graft-poly(ε-caprolactone) amphiphilic copolymer micelles for 5-fluorouracil drug delivery
Colloids Surfl B: Biol.
(2014) - et al.
Phagocytic activity of alveolar macrophages toward polystyrene latex microspheres and PLGA microspheres loaded with anti-tuberculosis agent
Colloids Surf. B: Biol.
(2007)
Delivery of rifampicin-PLGA microspheres into alveolar macrophages is promising for treatment of tuberculosis
J. Control. Release
Squalenoylation of chitosan: a platform for drug delivery?
Biomacromolecules
Development of chitosan nanoparticles as drug delivery systems for 5-fluorouracil and leucovorin blends
Carbohydr. Polym.
A novel and simple preparative method for uniform-sized PLGA microspheres: preliminary application in antitubercular drug delivery
Colloids Surf. B: Biol.
Arginine modified polymeric micelles as a novel drug delivery system with enhanced endocytosis efficiency
Colloids Surf. B: Biol.
Antibacterial activity directed isolation of compounds from Onosma hispidum
Microb. Res.
The blhavior of PLGA microspheres containing rifampicin in alveolar macrophages
Colloids Surf. B: Biol.
Tumor targeting using anti-her2 immuno liposomes
J. Control. Release
Organic solvent free low temperature method of preparation for self assembled amphiphilic poly(ε-caprolactone)-poly(ethylene glycol) block copolymer based nanocarriers for protein delivery
Colloids Surf. B: Biol.
Novel thiolated carboxymethyl chitosan-g-β-cyclodextrin as mucoadhesive hydrophobic drug delivery carriers
Carbohydr. Polym
Formation and characterization of chitosan-polylacticacid-polyethylene glycol-gelatin nanoparticles: a novel biosystem for controlled drug delivery
Carbohydr. Polym.
Hyaluronidase enzyme core-5-fluorouracil-loaded chitosan-PEG-gelatin polymer nanocomposites as targeted and controlled drug delivery vehicles
Int. J. Pharm.
Preparation of low toxic fluorescent chitosan-graft-polyethyleneimine copolymer for gene carrier
Carbohydr. Polym.
A new respirable form of rifampicin
Eur. J. Pharm. Biopharm.
Nanoparticle carriers based on copolymers of poly(ε-caprolactone) and hyperbranched polymers for drug delivery
J. Colloid Interface Sci.
Cited by (48)
Metal oxide nanocarrier for targeted drug delivery towards the treatment of global infectious diseases: A review
2023, Journal of Drug Delivery Science and TechnologyCurrent therapeutic delivery approaches using nanocarriers for the treatment of tuberculosis disease
2023, International Journal of PharmaceuticsChondroitin sulfate anchored biodegradable nanoparticles: Design, synthesis, and In-vitro anti-tubercular efficacy
2023, Materials Today CommunicationsFerulic acid-loaded drug delivery systems for biomedical applications
2022, Journal of Drug Delivery Science and TechnologyInsights into innovative therapeutics for drug-resistant tuberculosis: Host-directed therapy and autophagy inducing modified nanoparticles
2022, International Journal of PharmaceuticsCitation Excerpt :Based on their composition, other categories of NPs may include micelles, dendrimers, nanogels, inorganic NPs, and nanocapsules (Baranyai et al., 2020). Polymeric NPs have triggered a vast research interest as a drug delivery system due to their exceptional properties, including passive deposition in the target site, modified release biocompatibility and physicochemical stability (Praphakar et al., 2017). Furthermore, the hydrophilic outer core and hydrophobic inner core of polymeric NPs allow for the entrapment of various drugs within it (Praphakar et al., 2017).
Nanostructures for drug delivery in respiratory diseases therapeutics: Revision of current trends and its comparative analysis
2022, Journal of Drug Delivery Science and Technology